Kirin amgen house of lords pdf free

Uk supreme court introduces doctrine of equivalents gowling wlg. Kirin amgen inc v hoechst marion roussel ltd, reports of patent, design and trade mark cases, volume 122, issue 6, 1 january 2005, pages 169207. Last year, in kirin amgen v hoechst marion roussel ltd, the house of lords also ironed out some misconceptions that had developed in the application of the purposive construction rule in the uk. Single enantiomer claims are only infringed by a single. The role of the house of lords as the highest appeal court has since ended. The house of commons library has produced a briefing note about the decision not to proceed with the house of lords reform bill summary of the house of lords reform bill 2012 reform of the house of lords was a manifesto commitment for the three main parties at the 2010 election, and was included in the coalition agreement between the. Baroness jenkin of kennington, lord inglewood, lord haskel, lord faulks and baroness parminter take you on a tour around the house of lords. The plaintiff was employed by the defendants as manager of. The house of lords select committee for science and technology. The claims must be construed purposively following the well known house of lords authority on claim construction kirinamgen v hoechst marion roussel and others1.

Uk supreme court broadens scope of patent protection. Pdf the essential elements doctrine in patent infringement. Patent law purposive construction and article 69 epc person skilled in the art reads the claim or the specification on the assumption that its purpose is to. Dispute between kirinamgen inc amgen a very successful company and hoechst marion roussel ltd and transkaryotic therapies inc tkt concerning epuk 0148605b2, an early ep with earliest priority date late 1983 amgen patent relating to the production of erythropoietin epo by. His first approach to the problem was to consider the effect of applying a purposive construction as explained by the house of lords in kirin amgen v hoechst marion roussel 2004 ukhl 46, 2005 rpc 9. First report from the select committee of the house of lords on the trial of the earl russell. Epo is a hormone made in the kidney which stimulates the production of red blood cells by the bone marrow. He cited in support the decisions of the netherlands court of appeal in kirin amgen c. Its work complements that of the house of commons and this booklet illustrates examples of that work from the 200809. Patentinfringementerythropoietinrecombinant dna technologyconstruction of claimsprinciples of constructionrole of.

Ippt20041021, ukhl, kirin amgen v hoechst page 1 of 20 uk house of lords, 21 october 2004kirin, amgen v hoechst lands and germany certainly di. For the last decade, the most influential decision has been that of the house of lords in kirinamgen, in which lord hoffmann said, essentially, that all issues of infringement could be resolved by adopting a purposive construction to the language of the patent claim, so giving effect to what the person skilled in the art would have. Located in the conejo valley, amgen is the worlds largest independent biotechnology firm. Applying kirinamgen, the skilled person would not understand the racemate to fall within claim 1 6. In kirinamgen the house of lords held that when determining the scope of protection afforded to a patent. The board made these suggestions merely to speed up proceedings and the proprietor was free to take up these suggestions in a request. It is easy, whenever language of generality and relativity applicable to size, measure, weight or the like have been employed, to put puzzles which might indicate that, at certain points, you are at that thin strip of mechanical territory in which, on the one side. The context of this comment is within a discussion of the reliance which could be placed on the contents of the patent office file. Get free access to the complete judgment in kirin amgen inc and ors v. I use this framework to argue that lord hoffmanns critique of the essential. The claims must be construed purposively following the well known house of lords authority on claim construction kirin amgen v hoechst marion roussel and others2. For supporting teaching resources and downloads go to. A claim could cover uses of technology unknown at the time of drafting, but the court had to ask whether the person skilled in the art would.

Uk patent law decision since the house of lords judgment in kirinamgen, the supreme court has introduced, for the first time, an express doctrine of equivalents into uk patent law. As the authors explain below, this is likely to lead in future to a wider scope of protection for patents in. Aug 30, 2017 the essential resource for inhouse professionals. The house of lords is known for rigorously checking the detail of a bill, working to address potential problems and close any loopholes to make better, more effective laws. This position was confirmed in kirinamgen inc v hoechst marion roussel ltd 2004 ukhl 46 in which the alternative approach involving a literal construction with extension of protection outside the language of the claim to equivalents, as per the us doctrine of.

Lord hoffman, lord hope of craighead, lord rodger of earlsferry. The claims must be construed purposively following the well known house of lords authority on claim construction kirinamgen v hoechst marion roussel and others2. However article 12 epc states that the instances of the epo shall consider and decide upon the european patent only in the. Indeed, in kirinamgen the house of lords opined that article 69 fi rmly shuts the door on any doctrine which extends protection outside the claims. The supreme courts decision in actavis v eli lilly 2017 uksc 48 has changed the way that the uk courts will determine the extent of protection of a. The overriding question is what the person skilled in the art would have understood the patentee to have meant by the language of the claim. It also doubted the utility of the protocol questions, despite their regular application by the uk courts. In the case of virgin atlantic v premier aircraft, the court of appeal, summarising kirinamgen, explicitly stated it follows there. Kirinamgen inc v hoechst marion roussel ltd wikipedia. Kirinamgen inc amgen, a californian pharmaceutical company, is the proprietor of a european patent ep 0148605b2 relating to the production of erythropoietin epo by recombinant dna technology.

In kirin amgen, there was only one compulsory question. In a wideranging judgment which set out a clear guide to patent construction, lord hoffmann said 41. The aldous faction won the day with the definitive house of lords judgment by lord hoffmann in kirin amgen 2. House of lords sufficiency the question, according to lord mance. There is often discussion about whether we have a european doctrine of equivalents and, if not, whether we should. The work of the house of lords the house of lords as the second chamber of parliament. Stream adfree or purchase cds and mp3s now on amazon. The aldous faction won the day with the definitive house of lords judgment by lord hoffmann in kirinamgen 2. According to the principles enunciated by lord hoffmann, the words of the claim are to be construed having regard to the patentees purpose as. In order to navigate out of this carousel please use your heading shortcut key to navigate to the next or previous heading.

On december 20 2005, justice hughes, who recently rose to the bench of the federal court after a distinguished career as an ip. It is distinct from parliamentary privilege, which applies only to those peers serving in the house of lords and the members of the house of commons, while parliament is in session and forty days before and after a parliamentary session the privileges have been lost and eroded over time. Uk supreme court introduces doctrine of equivalents. This shopping feature will continue to load items when the enter key is pressed. The court of appeal, for whom the question did not arise, was inclined to agree with the judge. Dec 01, 2005 however, the house of lords decision in kirin amgen raises an important novelty issue. William brodie gurney et al, london, 1841 first report from the select committee of. In the most significant patent decision in a number of decades the house of lords in kirin amgen has to some extent rewritten the law on patent infringement.

Third report from the select committee of the house of lords on the trial of the earl russell. Oct, 2017 the supreme courts decision in actavis v eli lilly 2017 uksc 48 has changed the way that the uk courts will determine the extent of protection of a. The uk decision is in contrast to the us decision, in which the district court of massachusetts ruled in amgens favour on its epo patents. In kirin amgen the house of lords held that when determining the scope of protection afforded to a patent. To access this section, please start your free trial or log in. The house firmly aligned the english approach with harmonisation of patent law throughout. Tkt has confirmed the correct approach of proper construction of patent claims, as interpreted in the full light of the invention, to assess infringement. Kirinamgen inc v hoechst marion roussel ltd 2004 ukhl 46, 2 005 1 all er 667, 2005 rpc 169 at 185.

This approach is similar to the claim interpretation taken by the landmark english house of lords decision of kirinamgen inc v hoechst 2005. Slaughter and may house of lords clarifies english law. This requires that i put a purposive construction on the claims, interpreting them in the light of the description and drawings as instructed by section 1251 and take. The latest uk case law on claim interpretation is found in improver corp v remington consumer products ltd 1990 and the house of lords decision in kirinamgen 2004.

The privilege of peerage is the body of special privileges belonging to members of the british peerage. The uk decision is in contrast to the us decision, in which the district court of massachusetts ruled in amgen s favour on its epo patents. Second report from the select committee of the house of lords on the trial of the earl russell. Kirin amgen inc amgen, a californian pharmaceutical company, is the proprietor of a european patent ep 0148605b2 relating to the production of erythropoietin epo by recombinant dna technology. L ord hoffmann, now in the house of l ords, repudiated as a mang le the questions he had formulated in improve r. Uk supreme court broadens scope of patent protection law360. House of lords kirinamgen inc and others appellants v. Dispute between kirinamgen inc amgen a very successful company and hoechst marion roussel ltd and transkaryotic therapies inc tkt concerning epuk 0148605b2, an early ep with earliest priority date late 1983 amgen patent relating to the production of erythropoietin epo by recombinant dna technology. The house of lords considered that a doctrine of equivalents.

This position was confirmed in kirinamgen inc v hoechst marion roussel ltd 2004 ukhl 46 in which the alternative approach involving a literal construction with extension of protection outside the language of the claim to equivalents, as per the us doctrine of equivalents, was explicitly criticised. The judgment was issued on 21 october 2004 and relates to the scope to be accorded to patent claims, including the doctrine of equivalents. As the authors explain below, this is likely to lead in future to a wider scope of protection for patents in the united kingdom. The trial of james thomas, earl of cardigan before the right honourable the house of peers, in full parliament, for felony, on tuesday the 16th day of february 1841. The house of lords select committee for science and. However, the house of lords decision in kirinamgen raises an important novelty issue. In that case, the house of lords accepted the european patent office practice that productbyprocess claims could not be made unless the product itself was new, being different from any existing product in the state of the art, and that this difference could. Kirin amgen inc v hoechst marion roussel ltd 2004 ukhl 46, 2 005 1 all er 667, 2005 rpc 169 at 185. Stream ad free or purchase cds and mp3s now on amazon. In kirin amgen v hoechst marion roussel and others 2004 ukhl 46 lord hoffmans judgment with which the other judges concurred takes the view that what is in the claim is what matters. Never a freestanding reason for revocation kirinamgen. A little common sense would have settled all these differences in a few minutes. The law of patent construction in the uk has been largely settled since the 2004 house of lords decision in kirin amgen which, in confirming purposive construction as the correct approach, ruled out any usstyle doctrine of equivalence. Kirinamgen inc v hoechst marion roussel ltd reports of.

Sharer, president ceo wikipedia en francais kirinamgen v hoechst marion roussel kirin amgen, inc. One of the worlds largest independent biotechnology companies, amgen was established in thousand oaks, california in 1980. It also doubted the utility of the protocol questions, despite their regular application by the uk courts and the adoption of similar questions in other eu. The case and subsequent judgment affirmed principles from a prior case, catnic components ltd. Hoechst marion roussel ltd3 hereafter ka the house of lords exhibited a marked reluctance to jettison preepc uk jurisprudence and to embrace a new. Hoffmann, now in the house of lords, repudiated as a mangle the questions he. Jul, 2017 for the last decade, the most influential decision has been that of the house of lords in kirin amgen, in which lord hoffmann said, essentially, that all issues of infringement could be resolved by adopting a purposive construction to the language of the patent claim, so giving effect to what the person skilled in the art would have. Aug 09, 2017 uk supreme court broadens scope of patent protection. In 20, the companys largest selling product lines were neulastaneupogen, two closely related drugs used to prevent infections in patients undergoing. My lords, this is a most unfortunate litigation, in which the costs must far exceed any sum there may be at stake. Amgen s thousand oaks staff in 2017 numbered 5,125 7. Doctrine of equivalents wikimili, the free encyclopedia. The latest uk case law on claim interpretation is found in improver corp v remington consumer products ltd 1990 and the house of lords decision in kirin amgen 2004.

In the actavis decision lord neuberger states in the absence of good reason to the contrary, it would be wrong to depart from what was said by the house of lords in kirin amgen 2. Doctrine of equivalents wikipedia republished wiki 2. Actavis, he was free from such restriction, and the judgment has thus fittingly been. The law of patent construction in the uk has been largely settled since the 2004 house of lords decision in kirinamgen which, in confirming purposive construction as the correct approach, ruled out any usstyle doctrine of equivalence. This approach is similar to the claim interpretation taken by the landmark english house of lords decision of kirin amgen inc v hoechst 2005. Hoechst marion roussel ltd3 hereafter ka the house of lords exhibited a marked reluctance to jettison preepc uk.

This requires that i interpret the claims in the light of the description and drawings, to decide what a person skilled in the art would have understood the patentee to have. Its amendments may or may not be agreed by the house of commons, but the lords has a crucial ability to ask the government and commons to think again and, in some cases. House of lords clarifies english law on patent infringement nov 2004 client publicationarticle. List of trials of peers in the house of lords wikipedia. Their report on complementary and alternative medicine and its implications for reflexology author links open overlay panel iain wilkinson 3 rd year medical student at st georges hospital medical school, university of london, jan 2002 f1. There is no doctrine of equivalence under english law. The recently concluded litigation on kirinamgens erythropoietin patent in the united kingdom courts has added a further chapter to the intriguing saga. Amgens thousand oaks staff in 2017 numbered 5,125 7. The recently concluded litigation on kirin amgen s erythropoietin patent in the united kingdom courts has added a further chapter to the intriguing saga of recombinant dna patents and their. To view this article you need a pdf viewer such as adobe reader.

324 543 1099 76 1547 1139 326 1387 708 602 255 1195 538 1454 1426 917 572 67 1484 1308 354 106 60 1122 586 76 310 681 1258 640 1343 1571 1067 798 1084 1381 329 928 859 1190 907 105 441 1417 131